-
How to take the path of high-quality development of the pharmaceutical industry?
Time of Update: 2021-09-29
Compared with the traditional model, by embracing digitalization, pharmaceutical companies can greatly improve production efficiency, effectively reduce labor costs, and ensure drug safety, adding new impetus to the development of the entire pharmaceutical industry .
-
Eli Lilly’s application for new indications for IL-17A inhibitors is accepted by CDE
Time of Update: 2021-09-29
At present, the drug has been approved by the FDA to treat a variety of diseases, including moderate to severe plaque psoriasis, active psoriatic arthritis (PsA) in adult patients, ankylosing spondylitis, and active inflammation with objective symptoms non-radiological for axial spondyloarthritis (nr-axSpA) patients, and so on .
-
Frontier Bio-Akening obtained the "Drug Registration Certificate" approved and issued by Cambodia
Time of Update: 2021-09-29
On September 23, Frontier Bio announced that the company’s core product, Aikening, had recently received the "Drug Registration Certificate" approved and issued by the Ministry of Health of Cambodia .
-
Lihui Zou, Vice President of Fosun Pharma resigns
Time of Update: 2021-09-29
Lihui Zou .
Lihui Zou applied to the company's board of directors to resign from the position of vice president due to personal reasons .
Lihui Zou will no longer serve as the vice president of the company from September 22, 2021 .
-
Olin Biosorbent Tetanus Vaccine Obtained Drug Re-registration Approval Notice
Time of Update: 2021-09-29
Upon review, the company declared that the adsorbed tetanus vaccine complied with the "Administrative Measures for Drug Registration" 》, agree to re-register .
The company obtained the first registration approval for tetanus vaccine drug in October 2016.
-
Hunan Provincial Food and Drug Administration: "Practicing Pharmacist Registration Certificate" was invalidated by 77 personnel
Time of Update: 2021-09-29
The registration certificates of 77 licensed pharmacists in one province were revoked according to law, and the certificates were cancelled and invalidated . 77 licensed pharmacists whose registratio
-
Is it time to step down from the altar of dizocine, whose annual sales of 6.5 billion is questioned and abused?
Time of Update: 2021-09-29
Is Dezocine as the article said, does there really exist irrational use of the drug?Dingxiangyuan invited Ji Lianmei, the author of the article, Xu Jianguo, the corresponding author of "Expert Consensus on Dezocine Clinical Analgesia", and several anesthesiologists and pharmacists to discuss the many controversies surrounding dezocine .
-
PHOXBIO announces new coronary pneumonia preventive nasal spray
Time of Update: 2021-09-29
-pHOXWELL significantly reduces the risk of high-risk healthcare workers contracting the new coronavirus by 63%, and its tolerance is comparable to placebo-The new self-administered nasal spray is mai
-
High clinical demand and low market competition? Children's medicine may usher in explosive growth!
Time of Update: 2021-09-29
Table 1: "National Essential Drugs List (2018 Edition)" Chemical Drugs and Biological Products-Pediatric DrugsSource: Flint Creations compiled according to public informationTable 2: "National Essential Medicine List (2018 Edition)" Traditional Chinese Medicines-Pediatric DrugsSource: Flint Creations compiled according to public informationIt is undeniable that in recent years, the development of China's children's health industry has been actively improving, and the protection of children's medication has been continuously increased.
-
Qinghai: Zuo Tai, the Tibetan medicine "Treasure Zhongbao", witnessed the Silk Road exchanges and the industry looks forward to new things over time
Time of Update: 2021-09-29
China News Service, Xining, September 26th, title: Qinghai: Tibetan medicine "Treasure Zhongbao" Zuo Tai witnesses the Silk Road exchanges, the industry looks forward to longevityChina News Service reporter Zhang Tianfu"Zuotai" is one of the four major traditional medicines in the world.
-
JAK inhibitor Opzelura approved to treat atopic dermatitis
Time of Update: 2021-09-29
In addition, the drug also marked a black box warning, reminding patients that using JAK inhibitors to treat inflammation may cause serious infection, mortality, malignant tumors, major adverse cardiovascular events, and thrombosis .
Incyte Announces US FDA Approval of Opzelura™ (ruxolitinib) Cream, a Topical JAK Inhibitor, for the Treatment of Atopic Dermatitis (AD)
-
Centralized procurement of Chinese patent medicines in 19 places including Hubei and Hebei started!
Time of Update: 2021-09-29
According to the historical procurement data filled by the medical institutions in the alliance region, among the products of the same product group, the same company, and different dosage forms and specifications, the product with the largest purchase amount is used as the representative product for quotation, and the smallest retail package (such as: box) is used as the price.
-
Kelun Pharmaceutical Updates TROP-2 ADC Clinical Data and Newly Declares a Class 1 New Drug
Time of Update: 2021-09-29
Another patient with pancreatic cancer had stable disease after receiving SKB264 treatment, and the disease control time reached 30.
From: CSCO, official microblog of Kelun PharmaceuticalIn terms of safety, all 18 patients reported adverse events (AEs).
-
Zhang Boli: The coexistence of humans and viruses is a good wish, and the time is not yet ripe
Time of Update: 2021-09-28
Zhang Boli: The coexistence of humans and viruses is a good wish, and the time is not yet ripe.
On September 26, the "2021 World Internet Conference Wuzhen Summit-Global Anti-epidemic and International Communication Forum" hosted by China News Agency was held in Wuzhen, Zhejiang .
-
China CDC releases new version of influenza vaccination guidelines
Time of Update: 2021-09-28
China CDC released a new version of the influenza vaccination guidelines, recommending that these groups of people be given priority in vaccination China CDC released a new version
-
Health Commission: 66 newly diagnosed cases on the 18th, including 43 cases in the local area
Time of Update: 2021-09-28
As of 24:00 on September 18, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 927 confirmed cases (including 9 severe cases), a total of 90,126 cured and discharged cases, and a total of 4,636 deaths.
-
Merck and BMS will be under pressure in the future!
Time of Update: 2021-09-28
EP Vantage's latest analysis found that compared with 2019, almost all large pharmaceutical companies had improved their sales freshness index last year, with the exception of two companies-Amgen and Bristol-Myers Squibb (BMS) .
-
Health Commission: 28 newly diagnosed 43 local cases on the 22nd
Time of Update: 2021-09-28
As of 24:00 on September 22, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 990 confirmed cases (including 14 severe cases), a total of 90,268 cured and discharged cases, and a total of 4,636 deaths.
-
The politicization of virus origin
Time of Update: 2021-09-28
The reason for this situation is very clear: the elite class in the United States does not have effective governance capabilities, and fails to adopt the attitude that a normal country should have when facing the challenge of epidemics, that is, to follow the most basic basic ideas of infectious disease prevention and control.
-
Genetic sequencing of newly confirmed cases in Harbin shows Delta strain
Time of Update: 2021-09-28
Results of gene sequencing of newly confirmed cases in Harbin announced CCTV News (Reporter Li Wenxue) On the 24th, the Information Office of the Harbin Municipal People's Government held a press conference on epidemic prevention and control .
